Covered recipient · General Payments record
LUIS EYMARD JAVIER
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2022–2023
$1,213.78
- Reported across 41 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $543.59 | 17 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $240.49 | 8 |
| Acerta Pharma LLC | $128.22 | 2 |
| E.R. Squibb & Sons, L.L.C. | $33.49 | 1 |
| Amgen Inc. | $29.64 | 1 |
| Aurinia Pharma U.S., Inc. | $28.21 | 1 |
| GlaxoSmithKline, LLC. | $25.71 | 1 |
| Janssen Biotech, Inc. | $25.61 | 1 |
| Kowa Pharmaceuticals America, Inc. | $19.41 | 1 |
| SOBI, INC | $12.81 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $103.41 | 02/07/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1005711817 | CMS |
| ABBVIE INC. | $18.44 | 06/12/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1005711823 | CMS |
| ABBVIE INC. | $17.34 | 06/23/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1005711829 | CMS |
| ABBVIE INC. | $17.50 | 07/05/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1005711837 | CMS |
| ABBVIE INC. | $34.38 | 07/15/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1005711843 | CMS |
| ABBVIE INC. | $9.06 | 08/10/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1005711851 | CMS |
| ABBVIE INC. | $18.09 | 10/09/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1005711857 | CMS |
| ABBVIE INC. | $22.27 | 10/11/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1005711863 | CMS |
| Amgen Inc. | $29.64 | 01/10/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1020774139 | CMS |
| AstraZeneca Pharmaceuticals LP | $6.45 | 01/04/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1012100913 | CMS |
| AstraZeneca Pharmaceuticals LP | $121.77 | 10/11/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1011347057 | CMS |
| Aurinia Pharma U.S., Inc. | $28.21 | 01/19/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1057758709 | CMS |
| E.R. Squibb & Sons, L.L.C. | $33.49 | 01/24/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1015798967 | CMS |
| GlaxoSmithKline, LLC. | $25.71 | 01/04/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1004224269 | CMS |
| Janssen Biotech, Inc. | $25.61 | 01/06/2023 | Food and Beverage | Undisputed | 01/23/2026 | 988418311 | CMS |
| Kowa Pharmaceuticals America, Inc. | $19.41 | 01/18/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003904871 | CMS |
| SOBI, INC | $12.81 | 01/06/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1038078323 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023
- Source files
- Dataset page · Bulk file · PY2022 , PY2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.